Zhifei Wang
Overview
Explore the profile of Zhifei Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
216
Citations
2352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gao S, Jiang Y, Zhang L, Li J, Wang Y, Wang Z, et al.
RSC Adv
. 2025 Mar;
15(10):7318-7331.
PMID: 40061073
Three hydroxyl-containing cationic surfactants are synthesized and characterized by FTIR and HNMR, and their thermal stability is tested and analyzed. The surface activity, adsorption and aggregation behavior of the synthesized...
2.
Chen Z, Sun Z, Zhang Z, Lei C, Ren Z, Di Y, et al.
Front Oncol
. 2025 Mar;
15:1498927.
PMID: 40040724
Background: Some anti-diabetic drugs have been proved to be a tumor suppressor or activator. The associations of three relatively new classes of anti-diabetic medications-glucagon-like peptide-1 receptor agonists (GLP-1RA), dipeptidyl peptidase...
3.
Sun J, Zhao W, Zhang L, Wu S, Xue S, Cao H, et al.
Drug Resist Updat
. 2025 Mar;
80:101214.
PMID: 40023134
Aims: Temozolomide (TMZ) is the first-line chemotherapeutic agent for glioblastoma (GBM) therapy; however, resistance to TMZ remains a major obstacle in GBM treatment. The aim of this study is to...
4.
Luo K, Zhuang K, Wu H, Chen Y, Liu Y, Yang F, et al.
Cell Death Dis
. 2025 Jan;
16(1):48.
PMID: 39870645
Glioma is a common and destructive brain tumor, which is highly heterogeneous with poor prognosis. Developing diagnostic and prognostic markers to identify and treat glioma early would significantly improve the...
5.
Wang M, Cai X, Lv Q, Han J, Liu Q, Hu S, et al.
Langmuir
. 2025 Jan;
41(4):2427-2435.
PMID: 39866004
As one of the key diagnostic methods for detecting biomarkers and antigen-antibody interactions, the luminescent oxygen channel immunoassay (LOCI) has been widely applied in bioanalysis and other fields. In the...
6.
Deng X, Li H, Zhong Y, Wang H, Ke L, Wang Z, et al.
J Clin Transl Hepatol
. 2025 Jan;
13(1):1-14.
PMID: 39801784
Background And Aims: Liver cancer is a digestive system malignancy that poses a significant public health challenge globally. This study aimed to analyze and compare the epidemiological trends of liver...
7.
Liu Q, Yu J, Chen L, Han J, Cai X, Hu S, et al.
Talanta
. 2025 Jan;
286:127478.
PMID: 39765081
As a serine hydrolase synthesized by the liver, butyrylcholinesterase (BChE) is an important biomarker in the clinical diagnosis of liver diseases. To track BChE activity in drug-induced liver injury, we...
8.
Zhu Z, Amadi S, Mao J, Zhou M, Xia M, Parikh N, et al.
Sci Rep
. 2025 Jan;
15(1):636.
PMID: 39753693
Three-dimensional (3D) printed surgical models provide an excellent surgical training option to closely mimic real operations to teach medical students who currently rely largely on visual learning aided with simple...
9.
Chu X, Ma D, Yu J, Zhou J, Miao M, Hu S, et al.
Langmuir
. 2025 Jan;
41(1):1078-1085.
PMID: 39744781
This study aims to improve the signal-to-noise ratio (SNR) of chemiluminescence immunoassay (CLIA) by increasing the amount of protein immobilized on the surface of the magnetic bead (MB). Proteins are...
10.
Zhu Z, Mao J, Zhou M, Xia M, Wu J, Chen Q, et al.
Hernia
. 2024 Dec;
29(1):46.
PMID: 39666230
No abstract available.